Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project

Biobank Japan Cooperative Hospital Group

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: In Japanese males and females, lung cancer is currently the second and fourth most common type of cancer, and the first and second leading cause of cancer-related deaths, respectively. Methods: Of all Japanese male and female lung cancer patients aged ≥ 20 years whom the BioBank Japan Project originally enrolled between 2003 and 2008, 764 males and 415 females were registered within 90 days after their diagnosis. We described the lifestyle and clinical characteristics of these patients at study entry. Furthermore, we examined the effect of these characteristics on all-cause mortality. Results: In the lung cancer patients registered within 90 days, the frequencies of occult or stage 0, stage I, II, III and IV were 0.4%, 55.8%, 10.8%, 22.0% and 11.0% for males and 0.3%, 62.4%, 9.9%, 17.1% and 10.2% for females, respectively. The proportions of histological types in males and females were 56.3% and 82.4% for adenocarcinoma, 26.9% and 8.2% for squamous cell carcinoma, 4.5% and 1.5% for large cell carcinoma, 7.7% and 4.1% for small cell carcinoma and 4.6% and 3.8% for others, respectively. Among 1120 participants who registered within 90 days, 572 participants died during 5811 person-years of follow-up. Low body mass index, ever smoker, more advanced stage, squamous cell or small cell carcinoma and high serum carcinoembryonic antigen level at study entry were crudely associated with an increased risk of all-cause mortality after adjustment for age. Conclusions: This study showed the association of several lifestyle and clinical characteristics with allcause mortality in lung cancer patients.

Original languageEnglish
Pages (from-to)S49-S57
JournalJournal of epidemiology
Volume27
Issue number3
DOIs
Publication statusPublished - Jan 1 2017

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this